Institution RFA PI Name Award Value Asterias Biotherapeutics Strategic Partnership III Track A Jane Lebkowski A Phase I/IIa Dose Escalation Safety Study of [REDACTED] in Patients with Cervical Sensorimotor Complete Spinal Cord Injury $14,323,318